References
- Todd J, Fishaut M. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978: 2(8100): 1116–8
- Aranow H, Wood WB. Staphylococcic infection simulating scarlet fever. JAMA 1942: 119(18): 1491–5
- Stevens FA. The occurrence of Staphylococcus aureus infection with a scarlatiniform rash. JAMA 1927: 88(25): 1957–8
- Langmuir AD, Worthen TD, Solomon J, et al. The Thucydides syndrome: a new hypothesis for the cause of the plague of Athens. N Engl J Med 1985: 313(16): 1027–30
- Centers for Disease Control. Toxic shock syndrome associated with influenza: Minnesota. MMWR 1986: 35(9): 143–4
- Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance in the United States. 1980 to 1981. Ann Intern Med 1982: 96(6 Pt 2): 875–80
- Davis JP, Chesney PJ, Wand PJ, et al. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980: 303(25): 1429–35
- Sprung CL, Pons G, Schein RM. Shock. In: Gardner LB. ed. Textbook of acute internal medicine. New York: Elsevier Science Publishing, 1986: 656–66
- Todd JK, Ressman M, Caston SA, et al. Corticosteroid therapy for patients with toxic shock syndrome. JAMA 1984: 252(24): 3399–402
- Ciesielski CA, Broome CV. Toxic shock syndrome: still in the differential. J Crit Illness 1986: 1(6): 26–40
- Centers for Disease Control. Update: toxic-shock syndrome—United States. MMWR 1983: 32(30): 398–400
- Reingold AL. Nonmenstrual toxic shock syndrome: the growing picture. (Editorial) JAMA 1983: 249(7): 932
- Schlievert PM. Shands KN, Dan BB, et al. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 1981: 143(4): 509–16
- Bergdoll MS, Crass BA. Reiser RF, et al. A new staphylococcal enterotoxin, enterotoxin F. associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981: 1 (8228): 1017–21
- Bonventre PF, Weckbach L, Staneck J, et al. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun 1983: 40(3): 1023–9
- Mills JT, Parsonnet J, Tsai YC, et al. Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion. J Infect Dis 1985: 151 (6): 1158–61
- Garbe PL, Arko RJ, Reingold AL, et al. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome: evidence for additional toxins. JAMA 1985: 253(17): 2538–42